Summary of official information request
Total number of patients with Crohn's disease of ulcerative colitis to receive biologic treatments (infliximab, adalumimab) between 2016 and 2020 inclusive who were:
- White New Zealander
- Maori
- Asian (Ideally separated into South Asian and East Asian)
- Pacific Islanders by each ethnicity separately
